Heartstream Breaks Some Hearts
Executive SummaryHeartstream finally sold out to Hewlett-Packard at what observers believe was a disappointingly low price--below the IPO valuation. One problem: there weren't many available buyers for a company which has had trouble pioneering the brand new market for defibrillators that could be used by minimally trained personnel.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.